Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

被引:0
|
作者
Ian Naya
Lee Tombs
David A. Lipson
Isabelle Boucot
Chris Compton
机构
[1] Global Respiratory Franchise,Perelman School of Medicine
[2] GSK,undefined
[3] Precise Approach Ltd,undefined
[4] contingent worker on assignment at GSK,undefined
[5] Respiratory Research and Development,undefined
[6] GSK,undefined
[7] University of Pennsylvania,undefined
来源
关键词
COPD; Maintenance therapy; Exacerbation risk; ICS; Long acting bronchodilators; Lung function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
    Donohue, James F.
    Jones, Paul W.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 35 - 45
  • [42] Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety
    Tashkin, Donald P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (02) : 97 - 105
  • [44] Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease
    Jones, Paul W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (03) : 84 - 96
  • [45] Impact of Anxiety and Depression on Chronic Obstructive Pulmonary Disease Exacerbation Risk
    Laurin, Catherine
    Moullec, Gregory
    Bacon, Simon L.
    Lavoie, Kim L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (09) : 918 - 923
  • [46] Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
    Asche, Carl Victor
    Leader, Shelah
    Plauschinat, Craig
    Raparla, Swetha
    Yan, Ming
    Ye, Xiangyang
    Young, Dave
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 201 - 209
  • [47] One year change in health status in patients with stable Chronic Obstructive Pulmonary Disease (COPD) under long-acting bronchodilators treatment
    Wang, Chen
    Huang, Kewu
    Zheng, Jinping
    Guo, Yanfei
    Zhang, Hong
    Cao, Jie
    Zhang, Wei
    Hong, Xuchu
    Gu, Wei
    Wang, Xiaoge
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [48] Preoperative intervention with long-acting bronchodilators for the reduction of postoperative pulmonary complications in untreated patients with obstructive lung disease
    Mikami, Yu
    Jo, Taisuke
    Matsuzaki, Hirotaka
    Ishimori, Taro
    Saito, Minako
    Sakamoto, Yukiyo
    Yamauchi, Yasuhiro
    Takai, Daiya
    Yatomi, Yutaka
    Nagase, Takahide
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (02): : 92 - 101
  • [49] Can Dual Long-Acting Bronchodilator Therapy Prevent Clinically Important Deteriorations In Chronic Obstructive Pulmonary Disease? A Post Hoc Analysis Of The Zep117115 Trial
    Singh, D.
    Maleki-Yazdi, M.
    Tombs, L.
    Naya, I.
    Church, A.
    Iqbal, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [50] Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
    Bafadhel, Mona
    Peterson, Stefan
    De Blas, Miguel A.
    Calverley, Peter M.
    Rennard, Stephen I.
    Richter, Kai
    Fageras, Malin
    LANCET RESPIRATORY MEDICINE, 2018, 6 (02): : 117 - 126